| 000 | 01783 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517122234.0 | ||
| 264 | 0 | _c20171212 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1520-6017 | ||
| 024 | 7 |
_a10.1016/j.xphs.2016.08.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshiguro, Susumu | |
| 245 | 0 | 0 |
_aCombined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _c01 2017 |
||
| 300 |
_a385-394 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinoma, Lewis Lung _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA _xadministration & dosage |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aHIV-1 _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aPlasmids _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 2 _xgenetics |
| 650 | 0 | 4 |
_atat Gene Products, Human Immunodeficiency Virus _xchemistry |
| 700 | 1 | _aAlhakamy, Nabil A | |
| 700 | 1 | _aUppalapati, Deepthi | |
| 700 | 1 | _aDelzeit, Jennifer | |
| 700 | 1 | _aBerkland, Cory J | |
| 700 | 1 | _aTamura, Masaaki | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 106 _gno. 1 _gp. 385-394 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.xphs.2016.08.023 _zAvailable from publisher's website |
| 999 |
_c26539847 _d26539847 |
||